Last reviewed · How we verify
Rubidium Chloride Rb 82 (rubidium Rb-82 chloride)
At a glance
| Generic name | rubidium Rb-82 chloride |
|---|---|
| Sponsor | Bracco |
| Therapeutic area | Hematology |
| Phase | FDA-approved |
| First approval | 1989 |
Approved indications
- Positron emission tomography
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Rubidium Chloride Rb 82 CI brief — competitive landscape report
- Rubidium Chloride Rb 82 updates RSS · CI watch RSS
- Bracco portfolio CI